ArticleClinical ophthalmology (Auckland, N.Z.)2013

Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia.

Alexandros Rouvas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.